Online ISSN: 2515-8260

Keywords : SARS


Study Of Studies Related To Epidemiology Of COVID-19 And Public Health Risk Mitigation Strategies: A Review

Neha Thakur; Dr. Sakshi Sharma

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 4780-4796

The aim of this paper is to study some of widespread infectious epidemic diseases i.e. SARS, MERS and coronavirus which has been impacted global health and economy on vast scale. There are approximately 70,000 coronavirus cases from 2019 (COVID-19) are confirmed, of that over a pair of, 1000 patients are fatal and this disease turned out to be a serious threat to global health. The first approach of this paper is to have in-depth knowledge about the structure of coronavirus, its structural proteins i.e. S protein and their biological activities for the virus have been discussed. The second approach is to focus on different phases of epidemic and response interventions which are mandate to slow down the spread of any disease till its complete elimination this can help to accelerate further work on studies for managing future public health emergencies. Proper and cumulative planning at international/national/community levels and organized strategic preparation for prevention and control of such epidemic diseases is need of the prevailing global risk.

A DETAILS REVIEW OF SEVERE ACUTE RESPIRATORY SYNDROME

Dr..Gomathi M; Dr.Jaikumar S

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 5619-5626

The causative agent of coronavirus disease (COVID-19) has omnipresent worldwide spread, infecting more than two million people and causing over 150,000 deaths worldwide, resulting in devastating global health emergencies. Extreme acute respiratory syndrome 2 (sarkozydia) Early in its global expansion, the COVI-19 pandemic was further fuelled by insufficient access to laboratory research. Real-time RT-PCR Diagnostic Panel was the first test obtained from the US Food and Drug Administration on February 4, 2020, by the Centers for Disease Control and Prevention (CDC) 2019–Novel Coronavirus (2019–nCoV)1–3. This test was therefore introduced by a significant number of public health and clinical labs in the USA. Many manufacturers of commercial instruments then obtained EUAs for molecular SARS-CoV-2 identification. However, producers also assign reagents. Many of the clinical laboratories have therefore used several platforms to satisfy research criteria.

Coronavirus: A Review

Jaipreet .; Anu Bansal

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 5927-5935

Coronavirus is the emerging mutagenic pathogenic microorganism that is affecting the human beings in a larger extent. The name is given after its crown shaped like structure. In this review, structure and history of coronavirus is explained in detail. The history depicts the similarity and dissimilarity of novid coronavirus with preexisting SARS virus. Apart from that review also concludes about the mechanism of action of virus, how it spreads and transfer in human system. The symptoms and preventive measures are also discussed in the review.